首页> 外文OA文献 >Analysis of Phase II Studies on Targeted Agents and Subsequent Phase III Trials: What Are the Predictors for Success?

【2h】

Analysis of Phase II Studies on Targeted Agents and Subsequent Phase III Trials: What Are the Predictors for Success?

机译：针对目标药物和随后的III期试验的II期研究分析：成功的预测因素是什么？

页面导航

著录项
相似文献
相关主题

著录项

作者
John K. Chan; Stefanie M. Ueda; Valerie E. Sugiyama; Christopher D. Stave; Jacob Y. Shin; Bradley J. Monk; Branimir I. Sikic; Kathryn Osann;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Analysis of phase II studies on targeted agents and subsequent phase III trials: what are the predictors for success? [J] . Chan JK, Ueda SM, Sugiyama VE, Journal of Clinical Oncology . 2008,第9期

机译：分析针对靶向药物的II期研究和随后的III期试验：成功的预测因素是什么？
2. Analysis of phase II studies on targeted agents and subsequent phase III trials: what are the predictors for success? [J] . Chan JK, Ueda SM, Sugiyama VE, Journal of Clinical Oncology . 2008,第9期

机译：分析针对靶向药物的II期研究和随后的III期试验：成功的预测因素是什么？
3. Review of phase II trial designs used in studies of molecular targeted agents: outcomes and predictors of success in phase III. [J] . El-Maraghi RH, Eisenhauer EA Journal of Clinical Oncology . 2008,第8期

机译：审查用于分子靶向药物的II期试验设计：III期的结果和成功的预测因素。
4. Molecular Therapies in Hepatocellular Carcinoma beyond Sorafenib: Lessons from Failed Phase III Trials and Novel Targets [C] . Lipika Goyal, Andrew X. Zhu Gastrointestinal Cancers Symposium . 2014

机译：Sorafenib之外的肝细胞癌中的分子疗法：III期试验失败的课程和新型靶标
5. Clinical predictive value of pre-clinical cancer models: A study of the predictive value of the in vitro cell line, human xenograft and murine allograft pre-clinical cancer models for phase II clinical trials of cytotoxic cancer drugs [D] . Voskoglou-Nomikos, Theodora 2001

机译：临床前癌症模型的临床预测价值：体外细胞系，人异种移植和小鼠同种异体移植临床前癌症模型对细胞毒性癌症药物II期临床试验的预测价值研究
6. Analysis of early phase and subsequent phase III stroke studies of neuroprotectants: outcomes and predictors for success [O] . Jens Minnerup, Heike Wersching, Matthias Schilling, 2014

机译：神经保护剂的早期和随后的中风研究的分析：结果和成功的预测因素
7. Analysis of early phase and subsequent phase III stroke studies of neuroprotectants: outcomes and predictors for success [O] . Jens Minnerup, Heike Wersching, Matthias Schilling, 2014

机译：神经保护剂的早期和随后的中风研究的分析：结果和成功的预测因素

Analysis of Phase II Studies on Targeted Agents and Subsequent Phase III Trials: What Are the Predictors for Success?

著录项

相似文献

相关主题

期刊订阅